Issue Navigation
-
Review
-
151-156
Park CH, Noh JS, Jeon JP, Yokozawa T
Drug Discov Ther. 2023; 17(3):151-156.
DOI: 10.5582/ddt.2022.01097
-
157-169
The association of gut microbiome with recurrent pregnancy loss: A comprehensive review
Zhu J, Jin JX, Qi Q, Li LS, Zhou J, Cao WL, Wang L
Drug Discov Ther. 2023; 17(3):157-169.
DOI: 10.5582/ddt.2023.01010
-
170-176
Harmless and ecologically acceptable fabrication of long-acting injectable microspheres
Matsumoto A, Murakami M
Drug Discov Ther. 2023; 17(3):170-176.
DOI: 10.5582/ddt.2023.01008
-
177-182
Autoimmune hepatitis following COVID-19 vaccination: Clinical characteristics of 35 reported cases
Wang MR, Qi Juan, Liu YJ
Drug Discov Ther. 2023; 17(3):177-182.
DOI: 10.5582/ddt.2023.01022
-
183-190
Tanaka H, Satoh M, Takigawa M, Onoda T, Ishii T
Drug Discov Ther. 2023; 17(3):183-190.
DOI: 10.5582/ddt.2023.01007
-
191-200
The role of APOBEC3A in cervical cancer development and progression: A retrospective study
Zhang M, Wei Z, Zhao HB, Zhang S, Wu J, Zhou J, Wang Y, Wang L, Du Y
Drug Discov Ther. 2023; 17(3):191-200.
DOI: 10.5582/ddt.2022.01095
-
201-208
Sari DW, Minematsu T, Yoshida M, Kitamura A, Tomida S, Abe M, Khasanah U, Sanada H
Drug Discov Ther. 2023; 17(3):201-208.
DOI: 10.5582/ddt.2022.01119
-
209-213
Miyazawa D, Suzuki K, Sato H, Katsurayama N, Tahira T, Mizutani H, Ohara N
Drug Discov Ther. 2023; 17(3):209-213.
DOI: 10.5582/ddt.2023.01003
-
214-216
Inoue M, Nakadate K, Oosaki M, Shirota M, Yasu T
Drug Discov Ther. 2023; 17(3):214-216.
DOI: 10.5582/ddt.2022.01121
-
217-219
Ohya Y, Hayashida S, Yoneda A, Tsuji A, Inoue T, Chiyonaga S, Kuramoto K, Oda K, Iizaka M, Nakahara O, Inomata Y
Drug Discov Ther. 2023; 17(3):217-219.
DOI: 10.5582/ddt.2023.01009